Stauner James P 4
4 · UROPLASTY INC · Filed Nov 10, 2010
Insider Transaction Report
Form 4
Stauner James P
Director
Transactions
- Sale
common stock
2010-11-08$5.59/sh−28,600$159,934→ 27,125 total - Exercise/Conversion
non-qualified stock options
2010-11-08$1.82/sh−45,000$81,900→ 0 totalExercise: $1.82From: 2006-08-28Exp: 2011-08-27→ common stock (45,000 underlying) - Exercise/Conversion
common stock
2010-11-08$1.82/sh+45,000$81,900→ 55,725 total
Holdings
- 6,175
non-qualified stock options
Exercise: $4.16From: 2011-09-14Exp: 2017-09-13→ common stock (6,175 underlying) - 15,000
non-qualified stock options
Exercise: $0.77From: 2009-09-15Exp: 2014-09-14→ common stock (15,000 underlying)
Footnotes (3)
- [F1]Restricted stock subject to risk of forfeiture that lapses six months from the grant date (September 14, 2010).
- [F2]Fully vested.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions pursuant to a 10b5-1 plan adopted by Mr. Stauner in September 2010 at prices ranging from $5.50 to $5.74 per share, inclusive. The reporting person undertakes to provide to Uroplasty, Inc., any security holder of Uroplasty, Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).